HARVARD BIOSCIENCE, INC. (HBIO) Return on equity 2016–2025
HARVARD BIOSCIENCE, INC. (HBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-412.8%FY2025 · since FY2016: -6.0% → -412.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -412.8% | -393.3 pp |
| FY2024 | -19.6% | -14.9 pp |
| FY2023 | -4.7% | +8.5 pp |
| FY2022 | -13.2% | -12.8 pp |
| FY2021 | -0.3% | +9.8 pp |
| FY2020 | -10.2% | -4.4 pp |
| FY2019 | -5.7% | -2.2 pp |
| FY2018 | -3.5% | -2.5 pp |
| FY2017 | -1.1% | +4.9 pp |
| FY2016 | -6.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More HBIO financial trends
HBIO RevenueHBIO Net incomeHBIO Net marginHBIO Gross profitHBIO Gross marginHBIO Operating incomeHBIO Operating marginHBIO Operating cash flowHBIO Free cash flowHBIO Capital expendituresHBIO Stock buybacksHBIO Dividends paidHBIO Total assetsHBIO Total liabilitiesHBIO Shareholders’ equityHBIO overview →